Abstract
Enzalutamide and Docetaxel in Combination with Androgen Deprivation for Men with Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, A Phase II Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have